Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > ALTIMMUNE UK LIMITED
Company Information for

ALTIMMUNE UK LIMITED

CENTRAL SQUARE 5TH FLOOR, 29 WELLINGTON STREET, LEEDS, LS1 4DL,
Company Registration Number
02753142
Private Limited Company
Active

Company Overview

About Altimmune Uk Ltd
ALTIMMUNE UK LIMITED was founded on 1992-10-05 and has its registered office in Leeds. The organisation's status is listed as "Active". Altimmune Uk Limited is a Private Limited Company registered in ENGLAND with Companies House and the accounts submission requirement is categorised as SMALL
Key Data
Company Name
ALTIMMUNE UK LIMITED
 
Legal Registered Office
CENTRAL SQUARE 5TH FLOOR
29 WELLINGTON STREET
LEEDS
LS1 4DL
Other companies in NW1
 
Previous Names
VAXIN UK LIMITED01/09/2015
IMMUNE TARGETING SYSTEMS (ITS) LIMITED11/03/2015
Filing Information
Company Number 02753142
Company ID Number 02753142
Date formed 1992-10-05
Country ENGLAND
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 31/12/2022
Account next due 30/09/2024
Latest return 18/06/2016
Return next due 16/07/2017
Type of accounts SMALL
VAT Number /Sales tax ID GB850372536  
Last Datalog update: 2023-10-08 05:46:22
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for ALTIMMUNE UK LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of ALTIMMUNE UK LIMITED

Current Directors
Officer Role Date Appointed
WILLIAM JAMES ENRIGHT
Director 2015-03-11
Previous Officers
Officer Role Date Appointed Date Resigned
ELIZABETH ADKINS CZEREPAK
Director 2017-06-06 2018-05-08
CHRISTINE BRENNAN
Director 2016-09-08 2017-06-06
DAVID DRUTZ
Director 2015-03-11 2017-06-06
PHILIP LAWTON HODGES
Director 2015-03-11 2017-06-06
PHILIPPE JACQUES MICHEL POULETTY
Director 2007-06-28 2017-06-06
KLAUS OTTO SCHÄFER
Director 2015-03-11 2017-06-06
MARTEN STEEN
Director 2011-05-04 2017-06-06
FLORENT GROS
Director 2007-06-28 2016-09-08
BENJAMIN CHEN
Director 2012-08-30 2015-03-10
SANDY BLACKADDER PRIMROSE
Director 2007-11-29 2015-03-10
CARLTON BRADLEY BROWN
Director 2003-07-19 2012-07-09
JACOB UNO STANLEY GUNTERBERG
Director 2009-12-17 2011-05-04
KENNETH LESLIE POWELL
Director 2009-10-21 2011-03-18
DANIEL DRYSDALE ADAMS
Director 2007-06-28 2010-04-08
MARTIN JOSEPH BECKER
Director 2007-06-28 2010-04-08
BRENDA ELIZABETH REYNOLDS
Director 2008-12-11 2010-04-08
GUNNAR MAGNUS SEVERUS PERSSON
Director 2007-06-28 2009-12-17
GUNNAR MAGNUS SEVERUS PERSSON
Director 2007-06-28 2009-10-21
SANDRA WILLIAMS
Company Secretary 2009-02-26 2009-07-02
MICHAEL ANTHONY MCNAMARA
Company Secretary 2004-06-01 2009-02-26
DAVID HILL
Director 2004-08-10 2007-03-23
PHILIP JAMES HOLDEN SIZER
Director 2003-07-19 2005-06-01
CARLTON BRADLEY BROWN
Company Secretary 2003-07-19 2004-11-01
MICHAEL ANTHONY MCNAMARA
Director 1992-10-05 2003-07-19
DAVID HILL
Director 1993-10-05 2003-07-18
JOHN KARL SIMPSON
Director 1994-04-04 2003-07-18
WALTON LAW EDDLESTONE
Company Secretary 1992-10-05 2003-07-10
WATERLOW SECRETARIES LIMITED
Nominated Secretary 1992-10-05 1992-10-05
WATERLOW NOMINEES LIMITED
Nominated Director 1992-10-05 1992-10-05

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2023-08-04SMALL COMPANY ACCOUNTS MADE UP TO 31/12/22
2023-05-31Change of details for President Vipin Garg as a person with significant control on 2023-05-30
2023-05-31Director's details changed for President Vipin Garg on 2023-05-30
2023-05-30CONFIRMATION STATEMENT MADE ON 29/05/23, WITH NO UPDATES
2022-08-25SMALL COMPANY ACCOUNTS MADE UP TO 31/12/21
2022-08-25AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/21
2022-08-15RP04PSC01Second filing of notification of person of significant controlVipin Garg
2022-06-07CS01CONFIRMATION STATEMENT MADE ON 29/05/22, WITH NO UPDATES
2022-06-07RP04AP01Second filing of director appointment of President Vipin Garg
2022-05-17RP04AP01Second filing of director appointment of President Vipin Garg
2021-09-20AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/20
2021-06-01CS01CONFIRMATION STATEMENT MADE ON 29/05/21, WITH NO UPDATES
2021-05-17PSC02Notification of Altimmune, Inc. as a person with significant control on 2021-05-13
2020-12-17AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/19
2020-06-16CS01CONFIRMATION STATEMENT MADE ON 29/05/20, WITH NO UPDATES
2019-09-27AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/18
2019-06-25CS01CONFIRMATION STATEMENT MADE ON 29/05/19, WITH NO UPDATES
2019-04-15PSC01NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL VIPIN GARG
2019-04-15AP01DIRECTOR APPOINTED VIPIN GARG
2019-04-11PSC07CESSATION OF WILLIAM JAMES ENRIGHT AS A PERSON OF SIGNIFICANT CONTROL
2019-04-11TM01APPOINTMENT TERMINATED, DIRECTOR WILLIAM JAMES ENRIGHT
2018-12-19AD01REGISTERED OFFICE CHANGED ON 19/12/18 FROM London Bioscience Innovation Centre, 2 Royal College Street London NW1 0NH
2018-06-21AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/17
2018-06-12CS01CONFIRMATION STATEMENT MADE ON 12/06/18, WITH NO UPDATES
2018-05-22TM01APPOINTMENT TERMINATED, DIRECTOR ELIZABETH ADKINS CZEREPAK
2018-05-22PSC07CESSATION OF ELIZABETH ADKINS CZEREPAK AS A PERSON OF SIGNIFICANT CONTROL
2017-07-18PSC01NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL ELIZABETH ADKINS CZEREPAK
2017-07-18PSC01NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL WILLIAM JAMES ENRIGHT
2017-07-18PSC01NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL ELIZABETH ADKINS CZEREPAK
2017-07-03AP01DIRECTOR APPOINTED MRS. ELIZABETH ADKINS CZEREPAK
2017-07-02CS01CONFIRMATION STATEMENT MADE ON 18/06/17, WITH NO UPDATES
2017-06-27TM01APPOINTMENT TERMINATED, DIRECTOR KLAUS SCHÄFER
2017-06-27TM01APPOINTMENT TERMINATED, DIRECTOR PHILIPPE POULETTY
2017-06-27TM01APPOINTMENT TERMINATED, DIRECTOR PHILIP HODGES
2017-06-27TM01APPOINTMENT TERMINATED, DIRECTOR DAVID DRUTZ
2017-06-27TM01APPOINTMENT TERMINATED, DIRECTOR MARTEN STEEN
2017-06-27TM01APPOINTMENT TERMINATED, DIRECTOR CHRISTINE BRENNAN
2017-04-20AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/16
2016-11-10AAFULL ACCOUNTS MADE UP TO 31/12/15
2016-10-17AP01DIRECTOR APPOINTED DR. CHRISTINE BRENNAN
2016-10-13TM01APPOINTMENT TERMINATED, DIRECTOR FLORENT GROS
2016-06-30LATEST SOC30/06/16 STATEMENT OF CAPITAL;GBP 39123.11
2016-06-30AR0118/06/16 ANNUAL RETURN FULL LIST
2015-12-04AA01Current accounting period extended from 30/11/15 TO 31/12/15
2015-09-01RES15CHANGE OF NAME 26/08/2015
2015-09-01CERTNMCompany name changed vaxin uk LIMITED\certificate issued on 01/09/15
2015-09-01CONNOTNOTICE OF CHANGE OF NAME NM01 - RESOLUTION
2015-07-20LATEST SOC20/07/15 STATEMENT OF CAPITAL;GBP 2092801.01
2015-07-20AR0118/06/15 ANNUAL RETURN FULL LIST
2015-04-29MEM/ARTSARTICLES OF ASSOCIATION
2015-04-27AAFULL ACCOUNTS MADE UP TO 30/11/14
2015-03-31RES01ADOPT ARTICLES 11/03/2015
2015-03-25SH0110/03/15 STATEMENT OF CAPITAL GBP 2092529.15
2015-03-25SH08NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES
2015-03-23RES13COMPANY BUSINESS 13/02/2015
2015-03-23RES01ALTER ARTICLES 13/02/2015
2015-03-23AP01DIRECTOR APPOINTED DR KLAUS OTTO SCHÄFER
2015-03-17AP01DIRECTOR APPOINTED DR DAVID DRUTZ
2015-03-17AP01DIRECTOR APPOINTED MR WILLIAM JAMES ENRIGHT
2015-03-16AP01DIRECTOR APPOINTED MR PHILIP LAWTON HODGES
2015-03-11TM01APPOINTMENT TERMINATED, DIRECTOR SANDY PRIMROSE
2015-03-11TM01APPOINTMENT TERMINATED, DIRECTOR BENJAMIN CHEN
2015-03-11RES15CHANGE OF NAME 10/03/2015
2015-03-11CERTNMCOMPANY NAME CHANGED IMMUNE TARGETING SYSTEMS (ITS) LIMITED CERTIFICATE ISSUED ON 11/03/15
2015-03-11CONNOTNOTICE OF CHANGE OF NAME NM01 - RESOLUTION
2015-03-10SH0125/02/15 STATEMENT OF CAPITAL GBP 23173.18072
2015-01-23RES12VARYING SHARE RIGHTS AND NAMES
2015-01-23SH0130/11/14 STATEMENT OF CAPITAL GBP 23173.18
2014-08-13RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2014-07-24LATEST SOC24/07/14 STATEMENT OF CAPITAL;GBP 172254.73
2014-07-24AR0118/06/14 CHANGES
2014-04-15SH0128/03/14 STATEMENT OF CAPITAL GBP 172254.73
2014-04-14AAFULL ACCOUNTS MADE UP TO 30/11/13
2014-02-18RES13COMPANY MAY MAKE AN OFFER OR AGREEMENT TO ALLOT SHARE OR GRANT RIGHTS 16/01/2014
2014-02-18RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2013-07-25MEM/ARTSARTICLES OF ASSOCIATION
2013-07-25CC04STATEMENT OF COMPANY'S OBJECTS
2013-07-25RES01ALTER ARTICLES 04/07/2013
2013-07-12AR0118/06/13 FULL LIST
2013-06-24MISCSECTION 519
2013-03-12AAFULL ACCOUNTS MADE UP TO 30/11/12
2012-09-12AP01DIRECTOR APPOINTED DR BENJAMIN CHEN
2012-08-16RES137,0000000 FIXED RATE LOAN EQUAL WARRANTS 18/06/2012
2012-08-16RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2012-07-16SH0109/07/12 STATEMENT OF CAPITAL GBP 171885.87
2012-07-12AR0118/06/12 FULL LIST
2012-07-12TM01APPOINTMENT TERMINATED, DIRECTOR CARLTON BROWN
2012-05-16MEM/ARTSARTICLES OF ASSOCIATION
2012-05-16RES12VARYING SHARE RIGHTS AND NAMES
2012-05-16RES01ALTER ARTICLES 26/04/2012
2012-03-05AAFULL ACCOUNTS MADE UP TO 30/11/11
2011-12-12RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2011-12-12RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2011-12-06SH0103/10/11 STATEMENT OF CAPITAL GBP 162844.67
2011-10-25SH0126/09/11 STATEMENT OF CAPITAL GBP 161725.70
2011-07-15AR0118/06/11 FULL LIST
2011-05-24AP01DIRECTOR APPOINTED DR MARTEN STEEN
2011-05-23TM01APPOINTMENT TERMINATED, DIRECTOR JACOB GUNTERBERG
2011-05-18AAFULL ACCOUNTS MADE UP TO 30/11/10
2011-03-31TM01APPOINTMENT TERMINATED, DIRECTOR KENNETH POWELL
2010-11-17SH0110/11/10 STATEMENT OF CAPITAL GBP 125491.67
2010-09-23AR0123/08/10 FULL LIST
2010-09-15SH0123/08/10 STATEMENT OF CAPITAL GBP 92574.76
2010-07-13AAFULL ACCOUNTS MADE UP TO 30/11/09
2010-06-28AR0118/06/10 FULL LIST
2010-06-25CH01DIRECTOR'S CHANGE OF PARTICULARS / DR SANDY BLACKADDER PRIMROSE / 18/06/2010
2010-06-25CH01DIRECTOR'S CHANGE OF PARTICULARS / PHILIPPE JACQUES MICHEL POULETTY / 18/06/2010
2010-06-25CH01DIRECTOR'S CHANGE OF PARTICULARS / FLORENT GROS / 18/06/2010
2010-06-25CH01DIRECTOR'S CHANGE OF PARTICULARS / CARLTON BRADLEY BROWN / 18/06/2010
2010-04-19TM01APPOINTMENT TERMINATED, DIRECTOR DANIEL ADAMS
2010-04-19TM01APPOINTMENT TERMINATED, DIRECTOR MARTIN BECKER
2010-04-19TM01APPOINTMENT TERMINATED, DIRECTOR BRENDA REYNOLDS
2010-02-23RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2010-02-23RES01ALTER ARTICLES 09/02/2010
2010-02-16RES01ADOPT ARTICLES 09/02/2010
2010-02-08TM01APPOINTMENT TERMINATED, DIRECTOR GUNNAR PERSSON
2010-02-05AP01DIRECTOR APPOINTED MR JACOB UNO STANLEY GUNTERBERG
2009-12-23RES01ALTER ARTICLES 22/09/2009
2009-12-23MEM/ARTSARTICLES OF ASSOCIATION
2009-11-06AP01DIRECTOR APPOINTED GUNNAR MAGNUS SEVERUS PERSSON
2009-11-05AP01DIRECTOR APPOINTED DR KENNETH POWELL
2009-11-05TM01APPOINTMENT TERMINATED, DIRECTOR GUNNAR PERSSON
2009-07-15288bAPPOINTMENT TERMINATED SECRETARY SANDRA WILLIAMS
2009-07-01363aRETURN MADE UP TO 18/06/09; FULL LIST OF MEMBERS
2009-05-20AAFULL ACCOUNTS MADE UP TO 30/11/08
2009-05-20288cDIRECTOR'S CHANGE OF PARTICULARS / CARLTON BROWN / 30/11/2008
2009-03-09288bAPPOINTMENT TERMINATED SECRETARY MICHAEL MCNAMARA
2009-03-09288aSECRETARY APPOINTED SANDRA WILLIAMS
2009-02-17288aDIRECTOR APPOINTED BRENDA ELIZABETH REYNOLDS
2008-10-31363aRETURN MADE UP TO 05/10/08; FULL LIST OF MEMBERS
2008-08-27123NC INC ALREADY ADJUSTED 30/06/08
2008-08-27RES01ADOPT MEM AND ARTS 30/06/2008
2008-08-27RES04GBP NC 100000/200000 30/06/2008
2008-04-08AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/11/07
2008-02-29288aDIRECTOR APPOINTED DR SANDY BLACKADDER PRIMROSE
2008-02-26363sRETURN MADE UP TO 05/10/07; CHANGE OF MEMBERS
2007-09-12AATOTAL EXEMPTION SMALL ACCOUNTS MADE UP TO 30/11/06
2007-07-27SASHARES AGREEMENT OTC
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to ALTIMMUNE UK LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against ALTIMMUNE UK LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 0
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
ALTIMMUNE UK LIMITED does not have any mortgage charges so there is no mortgagee data available

  Average Max
MortgagesNumMortCharges0.338
MortgagesNumMortOutstanding0.178
MortgagesNumMortPartSatisfied0.001
MortgagesNumMortSatisfied0.168

This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology

Intangible Assets
Patents

Intellectual Property Patents Registered by ALTIMMUNE UK LIMITED

ALTIMMUNE UK LIMITED has registered 2 patents

GB2502716 , GB2465733 ,

Domain Names
We do not have the domain name information for ALTIMMUNE UK LIMITED
Trademarks
We have not found any records of ALTIMMUNE UK LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for ALTIMMUNE UK LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as ALTIMMUNE UK LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where ALTIMMUNE UK LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by ALTIMMUNE UK LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2014-12-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2014-11-0129371200Insulin and its salts, used primarily as hormones
2014-09-0129379000Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
2014-04-0129379000Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
2014-04-0130029090Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2014-03-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2014-01-0129379000Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
2014-01-0129420000Separate chemically defined organic compounds, n.e.s.
2014-01-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2013-09-0130021091Haemoglobin, blood globulins and serum globulins
2013-06-0129379000Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
2013-04-0130029010Human blood
2013-04-0130049000Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2013-01-0129224985Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine)
2012-08-0130021010Antisera
2012-08-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-07-0130029090Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2012-05-0129379000Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
2012-05-0130029090Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2012-04-0129349960Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
2012-04-0130021095
2012-04-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2012-03-0129029000Cyclic hydrocarbons (excl. cyclanes, cyclenes, benzene, toluene, xylenes, styrene, ethylbenzene and cumene)
2012-03-0129224985Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine)
2012-03-0129379000Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
2012-02-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2012-02-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-01-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2012-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-10-0137
2011-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-09-0130049000Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2011-08-0130021091Haemoglobin, blood globulins and serum globulins
2011-06-0129420000Separate chemically defined organic compounds, n.e.s.
2011-05-0129420000Separate chemically defined organic compounds, n.e.s.
2011-03-0129012900Hydrocarbons, acyclic, unsaturated (excl. ethylene, propene "propylene", butene "butylene" and isomers thereof and Buta-1,3-diene and isoprene)
2011-03-0130021099
2010-12-0129420000Separate chemically defined organic compounds, n.e.s.
2010-11-0128261910Fluorides of ammonium or of sodium
2010-11-0129420000Separate chemically defined organic compounds, n.e.s.
2010-09-0129225000Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function (excl. amino-alcohols, amino-naphthols and other amino-phenols, their ethers and esters and salts thereof, amino-aldehydes, amino-ketones and amino-quinones, and salts thereof, amino-acids and their esters and salts thereof)
2010-09-0130021095
2010-08-0129224985Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine)
2010-07-0128070010
2010-07-0129224985Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine)
2010-07-0130021095
2010-06-0128061000Hydrogen chloride "hydrochloric acid"
2010-05-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-03-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2010-03-0183099090Stoppers, caps and lids, incl. screw caps and pouring stoppers, capsules for bottles, threaded bungs, bung covers, seals and other packing accessories, of base metal (excl. crown corks, capsules of lead and capsules of aluminium of a diameter > 21 mm)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards
Technology Strategy Board Awards
ALTIMMUNE UK LIMITED has been awarded 2 awards from the Technology Strategy Board. The value of these awards is £ 2,175,095

CategoryAward Date Award/Grant
Pre-Clinical Development of a Novel Therapeutic Vaccine for Chronic Hepatitis B : Feasibility Study 2013-04-01 £ 2,025,095
Feasibility assessment of a novel vaccine platform for the stratified therapeutic vaccine intervention in non-small cell lung cancer. : Feasibility Study 2013-03-01 £ 150,000

How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.

European Union CORDIS Awards
The European Union has not awarded ALTIMMUNE UK LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.

    Copyright © Market Footprint Ltd GDPR statement
    Contact us   UK businesses for sale   Analysis of UK business loans
    S1